MDS Virtual Congress 2020 Archives - Page 57 of 149

Evaluation of the Body Weight Changes and Food Addiction in Parkinson’s Disease patient with Deep Brain Stimulation

I. Yakisikli, M. Saka, A. Zirh, B. Bolluk Kilic (Ankara, Turkey)
Evaluation of the effect of Bilateral Subthalamic Nucleus Deep Brain Stimulation on fatigue in Parkinson’s disease

C. Lazcano Ocampo, K. Ashkan, D. van Wamelen, M. Samuel, M. Silverdale, A. Rizos, H. Dafsari, A. Sauerbier, J. Koch, A. Podlewska, V. Leta, L. Timmermann, K. Chaudhuri (London, United Kingdom)
Evaluation of the Safety of Deutetrabenazine at Higher Doses to Treat Chorea in Huntington’s Disease

S. Frank, C. Vaughan, D. Stamler, D. Oakes, M. Davis, N. Gross, M. Gordon, J.M Savola, M. Wieman, S. Eberly, E. Kayson, J. Whaley, J. Goldstein, C. Testa (Boston, MA, USA)
Evidence towards the clinical benefits of using directional leads in Deep Brain Stimulation for movement disorders: Consecutive case series

M. Contreras, J. Saavedra, J. Espinoza, G. Arango, T. Lopez (La Serena, Chile)
Evolution of Freezing of Gait in Subthalamic Nucleus Deep Brain Stimulation

F. Alonso-Frech, V. Gomez-Mayordomo, M. del Valle-Loarte, C. Fernandez-Garcia, M. Hidalgo-Gonzalez, E. Lopez-Valdes, R. Garcia-Ramos, M. Catalán-Alonso (Madrid, Spain)
Examining the Effects of a Dental Mouthpiece on Motor Signs in Parkinson’s Disease

D. May, K. Rawson, D. Moeller, L. Tueth, R. Duncan, E. Harrison, A. Horin, P. Myers, G. Earhart (St. Louis, MO, USA)
Excessive Daytime Sleepiness in Parkinson’s disease and Narcolepsy Genetic Risk Allele HLA DQB1*0602

S. Azher, E. Molho, A. Hahn, O. Adam (Albany, NY, USA)
Experiences of people with Parkinson’s disease exercising at a centre and at home

A. Flynn, N. Allen, C. Canning, E. Preston, S. Dennis (Lidcombe, Australia)
Exploring cognitive aspect of linguistic prosody in Parkinson’s disease

A. Basirat, S. Pinto, K. Dujardin, L. Defebvre, D. Devos, C. Moreau (Lille, France)
Exploring dopamine transporter single-photon emission computed tomography quantification as a measure of disease progression in idiopathic Parkinson’s disease

J. Gurwell, R. El Khouli, G. Quintero, J. Slevin, M. Yazell, C. van Horne (Lexington, KY, USA)